Brief: Statera Biopharma Announces Revised Preliminary Revenue And Financial Results Of Fiscal Year 2021
08/03/2022 22:57
March 8 (Reuters) - Statera Biopharma Inc STAB.O :
* STATERA BIOPHARMA ANNOUNCES REVISED PRELIMINARY REVENUE
AND
FINANCIAL RESULTS OF FISCAL YEAR 2021
Source text for Eikon: ID:nGNXbHhlXp
Further company coverage: STAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc